口腔医学研究 ›› 2018, Vol. 34 ›› Issue (2): 107-111.DOI: 10.13701/j.cnki.kqyxyj.2018.02.001
• 专家特约述评 • 下一篇
胡勤刚, 王玉凤, 韩伟
收稿日期:2016-12-02
出版日期:2018-02-28
发布日期:2018-02-26
作者简介:胡勤刚 教授、主任医师,南京大学医学院口腔医学院、南京大学医学院附属口腔医院暨南京市口腔医院院长,南京大学博士生导师,中华口腔医学会常务理事,中国医师协会口腔医师分会副会长,江苏省整形美容协会会长,江苏省口腔医学会名誉会长,江苏省口腔科医疗质量控制中心主任,江苏省抗癌协会头颈肿瘤专业委员会名誉主任委员,江苏省医院协会口腔医院分会主任委员,享受国务院特殊津贴。获颁卫生部及江苏省有突出贡献中青年专家、"国际牙医师学院院士"和第八届南京市"十大科技之星"荣誉称号。担任《口腔医学研究》副主编,《中华口腔医学杂志》、《华西口腔医学杂志》、《实用口腔医学杂志》、《上海口腔医学杂志》、《口腔颌面外科杂志》、《中国口腔颌面外科杂志》编委。
基金资助:
Received:2016-12-02
Online:2018-02-28
Published:2018-02-26
中图分类号:
胡勤刚, 王玉凤, 韩伟. 肿瘤干细胞在头颈部鳞状细胞癌中的研究进展[J]. 口腔医学研究, 2018, 34(2): 107-111.
| [1] Zhang ZC,Jacques E. Nör. The biology of head and neck cancer stem cells [J]. Oral Oncol,2012,48(1)∶1-9 [2] Clark J,Li W,Smith G,et al. Outcome of treatment for advanced cervical metastatic squamous cell carcinoma [J]. Head Neck,2005,27(2)∶87-94 [3] Argiris A,Karamouzis MV,Raben D,et al. Head and neck cancer [J]. The Lancet,2008,371(9625)∶1695-1709 [4] Ghuwalewala S,Ghatak D,Das P,et al. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma [J]. Stem Cell Res,2016,16(2)∶405-417 [5] Prince ME,Zhou L,Moyer JS,et al. Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro [J]. Oral Oncol,2016,59∶30-42 [6] Tannishtha Reya SJM,Michael F. Clarke & Irving L,Weissman. Stem cells, cancer, and cancer stem cells [J]. Nature,2001,414(6859)∶105-111 [7] RitchieK. E NE. Perivascular stem cell niche in head and neck cancer [J]. Cancer Lett,2013,338(1)∶41-46 [8] Furth J,Kahn MC. The transmission of leukemia in mice with a single cell [J]. Am J Cancer,1937 [9] Lapidot T,Sirard C,Vormoor J,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice [J]. Nature,1994,367(4)∶645-648 [10] Al Hajj M,Wicha MS,Benito Hernandez A,et al. Prospective identification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci U S A,2003,100(7)∶3983-3988 [11] Prince ME,Sivanandan R,Kaczorowski A,et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma [J]. Proc Natl Acad Sci U S A,2007,104(3)∶973-978 [12] Mery B,Guy JB,Espenel S,et al. Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectives [J]. World J Stem Cells,2016,8(1)∶13-21 [13] Sudha Krishnamurthy ZD,Dmitry Vodopyanov,Atsushi Imai,et al. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells [J]. Cancer Res,2010,70(23)∶15 [14] Joshua B,Kaplan MJ,Doweck I,et al. Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness [J]. Head Neck,2012,34(1)∶42-49 [15] de Jong MC,Pramana J,van der Wal JE,et al. CD44 expression predicts local recurrence after radiotherapy in larynx cancer [J]. Clin Cancer Res,2010,16(21)∶5329-5338 [16] McCord AM,Jamal M,Williams ES,et al. CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines [J]. Clin Cancer Res,2009,15(16)∶5145-5153 [17] Zhang Q,Shi S,Yen Y,et al. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy [J]. Cancer Lett,2010,289(10)∶151-160 [18] Yuta Wakamatsu NS,Htoo Zarni Oo,Yutaka Naito,et al. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer [J]. Pathology International,2012,62(2)∶8 [19] Sophos NA,Vasiliou V. Aldehyde dehydrogenase gene superfamily: the 2002 update [J]. Chemico-Biological Interactions,2003,143-144∶5-22 [20] Christophe Ginestier,Min Hee Hur,Emmanuelle Charafe-Jauffret,et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome [J]. Cell Stem Cell,2007,1(5)∶555-567 [21] Sullivan JP,Spinola M,Dodge M,et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling [J]. Cancer Res,2010,70(23)∶9937-9948 [22] Chen YC,Chen YW,Hsu HS,et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer [J]. Biochem Biophys Res Commun,2009,385(3)∶307-313 [23] Koichi Shimano MS,Atsuhito Okaya,Junichi Kitanaka,et al. Hepatic Oval Cells Have the Side Population Phenotype Defined by Expression of ATP-Binding Cassette Transporter ABCG2/BCRP1 [J]. American Journal of Pathology,2003,163(1)∶3-9 [24] Hadnagy A,Gaboury L,Beaulieu R,et al. SP analysis may be used to identify cancer stem cell populations [J]. Exp Cell Res,2006,312(19)∶3701-3710 [25] Bragado P,Estrada Y,Sosa MS,et al. Analysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties [J]. PLoS One,2012,7(1)∶e29974 [26] Sun Q,Zhong Y,Wu F,et al. Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice [J]. BMC Med,2012,10∶172 [27] Spradling SJMaAC. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life [J]. Cell,2008,132(4)∶27 [28] Calabrese C,Poppleton H,Kocak M,et al. A perivascular niche for brain tumor stem cells [J]. Cancer Cell,2007,11(1)∶69-82 [29] Simple M,Suresh A,Das D,et al. Cancer stem cells and field cancerization of oral squamous cell carcinoma [J]. Oral Oncol,2015,51(7)∶643-651 [30] Albini A,Bruno A,Gallo C,et al. Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity [J]. Connect Tissue Res,2015,56(5)∶414-425 [31] Lee SW,Jeong HK,Lee JY,et al. Hypoxic priming of mESCs accelerates vascular-lineage differentiation through HIF1-mediated inverse regulation of Oct4 and VEGF [J]. EMBO Mol Med,2012,4(9)∶924-938 [32] Furuta E,Okuda H,Kobayashi A,et al. Metabolic genes in cancer: their roles in tumor progression and clinical implications [J]. Biochim Biophys Acta,2010,1805(2)∶141-152 [33] Keita Shibuya MO,Shuhei Suzuki,Manabu Seino,et al. Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells [J]. Oncotarget,2014,6()∶11 [34] Zhang W,Chen H,Lv S,et al. High CD133 Expression Is Associated with Worse Prognosis in Patients with Glioblastoma [J]. Mol Neurobiol,2016,53(2)∶2354-2360 [35] Clevers H. The cancer stem cell: premises, promises and challenges [J]. Nat Med,2011,17(3)∶313-319 [36] Lee SH,Koo BS,Kim JM,et al. Wnt/beta-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4 [J]. J Pathol,2014,234(1)∶99-107 [37] Lee SH,Oh SY,Do SI,et al. SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma [J]. Br J Cancer,2014,111(11)∶2122-2130 [38] Jordi Codony-Servat,Rafael Rosell. Cancer stem cells and immunoresistance: clinical implications and solutions [J]. Transl Lung Cancer Res,2015,4(6)∶689-703 [39] Lang R, Patel D, Morris JJ, et al. Shaping gene expression in activated and resting primary macrophages by IL-10 [J]. J Immunol, 2002, 169∶2253-63 [40] Kortylewski M, Kujawski M, Wang T, et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity [J]. Nat Med,2005,11∶1314-21 [41] Jin L,Hope KJ,Zhai Q,et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells [J]. Nat Med,2006,12(10)∶1167-1174 [42] Marion Gilormini,Céline Malesys,Emma Armandy,et al. Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC [J]. Oncotarget,2016,7(13)∶16731-16744 [43] Harrison H,Farnie G,Howell SJ,et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor [J]. Cancer Res,2010,70(2)∶709-718 [44] Silvia Santamaria,Marisa Delgado,Leonor Kremer,et al. Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible [J]. Front Immuol, 2017, 8∶1509 [45] Loebinger MR,Giangreco A,Groot KR,et al. Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade [J]. Br J Cancer,2008,98(2)∶380-387 [46] Moreb JS, Ucar-Bilyeu DA, Khan A. Use of retinoic acid/aldehyde dehy-drogenase pathway as potential targeted therapy against cancer stem cells [J]. Cancer Chemother Pharmacol,2017,79(2)∶295-301 [47] Cimmino L, Dolgalev I, Wang Y, et al. Restoration of TET2 function blocks aberrant self-renewal and leukemia progression [J]. Cell,2017,170∶1079-95 |
| [1] | 邹海啸, 杨海丽, 赵怡芳, 宋莉. 普萘洛尔对人黑色素瘤A375细胞增殖迁移和血管生成能力的影响及其机制研究[J]. 口腔医学研究, 2018, 34(2): 139-143. |
| [2] | 秦帅华, 李新明, 李文鹿. 修复重建后口腔癌患者生存质量的影响因素分析[J]. 口腔医学研究, 2018, 34(2): 144-147. |
| [3] | 邓轩, 阳芳. MUC1-siRNA对人舌癌Tca细胞迁移、侵袭及PI3K-Akt信号通路的影响[J]. 口腔医学研究, 2018, 34(2): 148-151. |
| [4] | 张厚华, 范华俐. RNA干扰沉默钙蛋白酶1对口腔鳞状细胞癌细胞株HSC3增殖和迁移的影响[J]. 口腔医学研究, 2018, 34(2): 152-156. |
| [5] | 王丽, 李建国. 右美托咪定用于口腔癌前臂皮瓣修复术后保留气管插管患者的镇静研究[J]. 口腔医学研究, 2018, 34(2): 157-160. |
| [6] | 刘玉兰, 孟琳, 唐琪, 布文奂, 黄国帅, 戴义宾, 刘麒麟, 孙宏晨. 抗坏血酸碳点通过促进自噬杀伤舌鳞癌细胞[J]. 口腔医学研究, 2018, 34(1): 35-38. |
| [7] | 周雄明, 那思家, 潘淑婷, 邱嘉旋. 白花丹素对舌鳞状细胞癌细胞的侵袭和迁移的作用及机制研究[J]. 口腔医学研究, 2018, 34(1): 39-43. |
| [8] | 曾光,卫克文. MAP4K3-mTOR信号在甘草查而酮A诱导的鳞癌细胞自噬与凋亡中的作用研究[J]. 口腔医学研究, 2017, 33(12): 1241-1245. |
| [9] | 徐晓芳,贾晓威,梁立中. miR-30d在舌鳞状细胞癌组织中表达及反义miR-30d对细胞增殖、侵袭能力的影响[J]. 口腔医学研究, 2017, 33(12): 1262-1265. |
| [10] | 张红超,刘云青,邵明敬,王翠萍,毕良佳,孟培松. AE-PDT对裸鼠舌鳞癌治疗效果的初步探讨[J]. 口腔医学研究, 2017, 33(12): 1266-1269. |
| [11] | 唐彩金,曾启新,方梅飞,马飞,陶人川,Niyukty Arjal. 消退素D1治疗实验性大鼠牙周炎的研究[J]. 口腔医学研究, 2017, 33(12): 1270-1273. |
| [12] | 吴昌敬,王蔚璐,甄恩明,邵军. YAP1小干扰RNA对舌鳞状细胞癌生物学特性的影响[J]. 口腔医学研究, 2017, 33(12): 1278-1281. |
| [13] | 邬利波,潘淑婷,邱嘉旋. 口腔鳞癌新辅助化疗前后多药耐药相关蛋白的表达及临床疗效分析[J]. 口腔医学研究, 2017, 33(12): 1298-1301. |
| [14] | 王丽萍, 郭雪琪, 闫勇勇, 査骏, 陈伟鸿, 魏永祥, 朱昕欣, 管红兵, 葛林虎. miR-146a在口腔鳞癌组织及细胞中的表达及功能研究[J]. 口腔医学研究, 2017, 33(11): 1204-1208. |
| [15] | 徐飞, 王姗, 孟琰, 施磊, 强冬霞, 赵尔杨. SOX2在口腔鳞癌中的表达及其与EMT的相关性[J]. 口腔医学研究, 2017, 33(11): 1209-1212. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
